Sagimet Biosciences Inc. (SGMT)
NASDAQ: SGMT · Real-Time Price · USD
5.96
-0.10 (-1.65%)
At close: Dec 26, 2025, 4:00 PM EST
5.94
-0.02 (-0.34%)
After-hours: Dec 26, 2025, 7:58 PM EST
Sagimet Biosciences Market Cap
Sagimet Biosciences has a market cap or net worth of $193.83 million as of December 26, 2025. Its market cap has increased by 19.22% in one year.
Market Cap
193.83M
Enterprise Value
68.44M
1-Year Change
19.22%
Ranking
Category
Stock Price
$5.96
Market Cap Chart
Since the IPO on July 14, 2023, Sagimet Biosciences's market cap has decreased from $354.80M to $193.83M, a decrease of -45.37%. That is a compound annual growth rate of -21.87%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 24, 2025 | 197.08M | 36.03% |
| Dec 31, 2024 | 144.88M | 16.75% |
| Dec 29, 2023 | 124.10M | -65.02% |
| Jul 14, 2023 | 354.80M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 959.53B |
| Johnson & Johnson | 495.78B |
| AbbVie | 404.36B |
| UnitedHealth Group | 294.22B |
| AstraZeneca | 287.19B |
| Novartis AG | 267.64B |
| Merck & Co. | 260.71B |
| Novo Nordisk | 232.28B |